169206 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Sub-classes:FLAGELLIN EPITOPE PEPTIDES AND USES THEREOF
#2METHODS AND KITS FOR MEASURING THREE OR MORE TAU EPITOPES
#3USE OF MONOLITHIC ANION EXCHANGE CHROMATOGRAPHY AND LIGHT SCATTERING FOR QUANTIFYING EXTRACELLULAR VESICLES
#4LANTHANIDE-TEMPLATED PROTEIN DIMERIZATION AND FINER RARE EARTH SEPARATION
#5ASSAY DEVICE AND TARGET MOLECULE TESTING METHOD
#6Methods for Standardizing Lectin Reagents, IgA1 Calibration Standards, and Quantitative Measurement of Galactose-Deficient IgA1 in Human Samples
#7METHODS FOR IDENTIFYING SUBJECTS AT RISK OF THROMBOSIS OR MALIGNANCY
#8PORTABLE SUSPENDED MICROORGANISM ANALYSIS DEVICE
#9ENDOGLIN ANTIBODIES AND USES THEREOF
#10DETECTING XENOTRANSPLANT ORGAN REJECTION
#11CAPACITIVE SENSOR AND METHOD OF USE
#12SYSTEMS, DEVICES AND METHODS FOR CELL CAPTURE AND METHODS OF MANUFACTURE THEREOF
#13PEPTIDES WITH CYTOKINE-RELEASING ACTIVITY AND METHODS FOR CHARACTERIZING CYTOKINE-RELEASING PROFILES OF PEPTIDES
#14IMMUNOASSAY SYSTEM
#15SINGLE-MOLECULE PEPTIDE SEQUENCING USING GUANIDINYLATING AGENTS
#16Ballistic microscopy (BaM): High-throughput cytoplasm spatio-temporal pico-sampling from live-single cells for omic studies using particle bombardment
#17BIOSENSORS COMPRISING AMPHIPHILIC POLYMERS AND USE THEREOF
#18KIT FOR DIAGNOSING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE
#19COMPOSITIONS, DEVICES, AND METHODS OF FUNCTIONAL DYSPEPSIA SENSITIVITY TESTING
#20SPATIALLY ENCODED BIOLOGICAL ASSAYS
#21SOLID PHASE LIBRARY PREPARATION FOR POLYPEPTIDE SEQUENCING
#22DOC2B AS A BIOMARKER FOR TYPE 1 AND TYPE 2 DIABETES
#23COMPOSITIONS, DEVICES, AND METHODS OF CROHN'S DISEASE SENSITIVITY TESTING
#24COMPOSITIONS, DEVICES, AND METHODS OF GASTROESOPHAGEAL REFLUX DISEASE SENSITIVITY TESTING
#25MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#26CYCLOSPORINE-ACRIDINIUM ESTERS AND METHODS OF PRODUCTION AND USE THEREOF
#27COMPOSITIONS, DEVICES, AND METHODS OF DEPRESSION SENSITIVITY TESTING
#28NEUTRALIZATION ANTIBODY ASSAY METHOD
#29ANALYTE DETECTION USING APTAMERS
#30AFFINITY SCREENING METHOD
#31CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS
#32Assessment of immune cells in the uterine fluid at the time of the embryo transfer
#33Systems, Methods, and Compositions for Selecting or Isolating Cells
#34MICROFLUIDIC DEVICE FOR ANALYZING STEADY STATE BIOLOGICAL REACTIONS
#35SPATIAL TARGETING OF ANALYTES
#36COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES
#37SARS-COV-2 POLYPEPTIDE, ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF
#38METHOD OF DETERMINING THE PRESENCE AND/OR AMOUNT OF TARGET MOLECULES
#39PH-GRADIENT SPR-BASED BINDING ASSAY
#40SPATIALLY ENCODED BIOLOGICAL ASSAYS
#41SINGLE-DOMAIN HIGH AFFINITY ANTIBODIES AND METHODS OF USE THEREOF
#42METHODS OF AAV THERAPY
#43CALPROTECTIN BINDING PEPTIDES
#44VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE
#45METHODS TO DETECT AB PROTEOFORMS AND USE THEREOF
#46MULTI-CHAMBERED ASSAY DEVICES AND ASSOCIATED METHODS, SYSTEMS AND APPARATUSES THEREOF FOR DETECTION OF ANALYTES
#47ANTI-FEL D 1 ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF AND USES THEREOF
#48METHODS FOR ANALYZING TRANSFERRIN GLYCOFORMS
#49METHODS OF USING SHAPED PARTICLES IN FLOW CYTOMETERS FOR ASSAYS ON B CELLS AND T CELLS
#50DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1)
#51SYSTEMS AND PROCESSES TO SCREEN FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) OF 2019 (COVID-19)
#52ARTICLES AND METHODS FOR ANALYTE CONCENTRATION MEASUREMENTS
#53SARS-COV-2 N PROTEIN-SPECIFIC SINGLE-CHAIN ANTIBODY, AND FUSION PROTEIN AND USE THEREOF
#54VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE
#55ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF
#56ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR ANTI-BSEP AUTOANTIBODY
#57HRG MEASURING METHOD USING ANTI-HRG MONOCLONAL ANTIBODIES
#58METHODS AND REAGENTS OF IMMUNOLOGICALLY DETECTING SARS-CoV-2
#59COTTON LEAFROLL DWARF VIRUS-BINDING ANTIBODIES AND USES THEREOF
#60KITS AND METHODS TO DISTINGUISH FALSE LABOR AND TRUE LABOR
#61ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF II
#62HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION
#63BIOMARKERS FOR OVARIAN CANCER
#64METHOD FOR TRANSPLANT ORGAN HEALTH ASSESSMENT
#65DETECTION AND QUANTIFICATION OF ANTI-DRUG ANTIBODIES AND ANTI-SELF ANTIBODIES
#66OLFACTORY RECEPTOR GENE FOR DIAGNOSING SKIN AGING AND USE THEREOF
#67AFFINITY CHROMATOGRAPHY LIGANDS FOR ANTIBODY GLYCOVARIANT SEPARATION
#68ENGINEERING OF MULTIFUNCTIONAL PEPTIDES FOR CONTROLLED DRUG DELIVERY
#69Human Epidermal Growth Factor Receptor Binding Molecule and Use Thereof
#70ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T
#71SPATIALLY ENCODED BIOLOGICAL ASSAYS
#72SPATIALLY ENCODED BIOLOGICAL ASSAYS
#73PHOSPHORYLATION OF P53 AS A PROGNOSTIC OR DIAGNOSTIC MARKER FOR THE TREATMENT OF SENESCENT CELLS IN A MAMMAL
#74NANO-COULTER COUNTER FOR DETECTION OF BIOLOGICAL NANOPARTICLES
#75METHOD FOR DIAGNOSING ACUTE EXACERBATION OF BRONCHIECTASIS AND KIT THEREFOR
#76METHODS OF CLASSIFYING RESPONSE TO IMMUNOTHERAPY FOR CANCER
#77METHODS AND SYSTEMS FOR USING ISOTOPICALLY LABELED ANALYTES FOR CALIBRATION FOR QUANTIFICATION OF ANALYTES IN DRIED SAMPLES
#78SINGLE CELL PROTEOMICS USING DEGRADABLE HYDROGELS
#79RECOMBINANT ANTIBODY, KIT COMPRISING THE SAME, AND USES THEREOF IN DIAGNOSING CANCERS
#80ANTIBODY LIBRARIES
#81SPATIALLY ENCODED BIOLOGICAL ASSAYS
#82SPATIALLY ENCODED BIOLOGICAL ASSAYS
#83SPATIALLY ENCODED BIOLOGICAL ASSAYS
#84Methods for Multiplex Imaging Using Labeled Nucleic Acid Imaging Agents
#85HYDROGEL CHANNEL DEVICE WITH SENSOR
#86METHODS AND SYSTEMS FOR DIAGNOSING ORTHOPOXVIRUS INFECTION
#87Multiplexed Analyses of Test Samples
#88METHODS FOR USE OF VIRAL VECTOR CONSTRUCTS FOR THE TREATMENT OF FABRY DISEASE
#89INDICATOR-BASED ANALYSIS OF A SAMPLE
#90Device and Methods
#91METHOD FOR DETERMINATION OF MUTATED FORM OF MUCIN-1 PROTEIN IN A BIOLOGICAL SAMPLE
#92INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION
#93Spatially encoded biological assays
#94Spatially encoded biological assays
#95METHODS OF USE OF ANTI-TREM2 ANTIBODIES
#96ANALYSIS AND SCREENING OF CELL SECRETION PROFILES
#97ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES
#98CARDIAC CALCIUM HANDLING MACHINERY REMODELED IN FRIEDREICH'S ATAXIA
#99AUTOFOCUS SAMPLE IMAGING APPARATUS AND METHOD
#100ALKALI-TOLERANT MUTATION METHOD OF PROTEIN A
#101DETECTION METHOD AND DETECTION REAGENT
#102NOVEL POTENCY ASSAY FOR ANTIBODY-BASED DRUGS AND USEFUL MEANS THEREFOR
#103Method and reagents for the detection of a mammalian antibody
#104Tissue-Specific Extracellular Vesicle Isolation and Validation
#105Assays for Quantification of Anti-HPA-1a Antibodies
#106BIOCHEMICAL REACTION SUBSTRATE AND ANALYZER
#107SYNTHETIC CONTROLS FOR IMMUNOHISTOCHEMISTRY
#108METHODS AND SYSTEMS FOR DETECTING ANTIBODIES BY SURFACE PLASMON RESONANCE
#109INCENP TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER
#110METHOD OF ANALYSING A SAMPLE FOR AT LEAST ONE ANALYTE
#111METHOD OF DIAGNOSING A CONDITION USING MICROBIOME DATA
#112Spatially encoded biological assays
#113LABELING AND ANTI-DRUG ANTIBODY ASSAYS FOR AAV VECTORS
#114BIOMARKERS FOR ASSESSING THE RESPONSE STATUS FOR TREATMENT OF INFLAMMATORY CONDITION OR DISEASE AFFECTING THE DIGESTIVE TRACT SUCH AS INFLAMMATORY BOWEL DISEASE IN HUMAN PATIENTS
#115AGGLUTINATING AGENTS, DEVICES AND METHODS FOR WHOLE BLOOD ASSAYS
#116Rapid Bio/Chemical Assay
#117POINT OF SERVICE METHOD OF DETECTING, DIAGNOSING AND FOLLOWING CANCER AND OTHER PROLIFERATIVE CONDITIONS
#118BIOMARKERS TO DETECT RISK OF SINUSOIDAL OBSTRUCTION SYNDROME
#119A NOVEL ANTIBODY FOR DETECTION OF AMYLOID BETA 42 (AB42)
#120METHOD FOR MEASURING EXTRACELLULAR VESICLES, METHOD FOR ACQUIRING INFORMATION ON NEURODEGENERATION, METHOD FOR ISOLATING EXTRACELLULAR VESICLES, AND REAGENT KIT
#121ANTIBODY SPECIFIC FOR ANTI-BCL-6 ANTIBODY AND METHODS OF USE
#122SAMPLE PROCESSING DEVICE
#123Automated Mass Spectrometry Sampling of Material Surfaces
#124Cilia Protein as Biomarkers and Methods of Use
#125Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission
#126ASSAY USING DIFFERENT SPACING HEIGHTS
#127SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS
#128MODIFIED TNF AS A CAPTURE LIGAND
#129COMBINATION TREPONEMAL AND NON-TREPONEMAL SYPHILIS TEST
#130NON-INVASIVE CANCER DETECTION AND ANALYSIS BY SINGLE-MOLECULE IMAGING
#131ISOTHERMAL GENE AMPLIFICATION METHOD, GENE DETECTION METHOD, VIRUS DETECTION METHOD, AND KIT USED THEREFOR
#132ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1 ANTIBODIES AND METHODS FOR USES THEREOF
#133SATURATION BINDING RATIOMETRIC ASSAY
#134TRANSKETOLASE EPITOPES, METHODS, AND DEVICES FOR IGG-BASED TUBERCULOSIS SERODIAGNOSIS
#135METHOD FOR DETERMINING THE AMOUNT OF A THERAPEUTIC ANTIBODY IN THE BRAIN
#136LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE
#137METHODS FOR CHARACTERIZING LENTIVIRUSES
#138Kits and methods to distinguish false labor and true labor
#139SYSTEMS AND PROCESSES TO SCREEN FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) OF 2019 (COVID-19)
#140METHOD FOR TREATING BIOLOGICAL SAMPLE
#141FLUIDIC DEVICE FOR THE DETECTION, CAPTURE, OR REMOVAL OF A DISEASE MATERIAL
#142METHODS AND ARRAYS FOR TARGET ANALYTE DETECTION AND DETERMINATION OF TARGET ANALYTE CONCENTRATION IN SOLUTION
#143MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF
#144ANTIBODIES AND ASSAYS FOR CCL14
#145SURFACE ENHANCED RAMAN SPECTROSCOPIC METHODS FOR DETECTING ANALYTES
#146SPATIALLY ENCODED BIOLOGICAL ASSAYS
#147CAPACITIVE SENSOR AND METHOD OF USE
#148SWITCHING PEPTIDE AND MULTIPLEX IMMUNOASSAY METHOD USING SAME
#149ANALYSIS METHOD
#150IDENTIFICATION OF SARS-COV-2 EPITOPES DISCRIMINATING COVID-19 INFECTION FROM CONTROL AND METHODS OF USE
#151METHODS FOR MAINTAINING THE INTEGRITY AND IDENTIFICATION OF A NUCLEIC ACID TEMPLATE IN A MULTIPLEX SEQUENCING REACTION
#152Device and method for detection of analytes
#153COMPOSITION FOR DETECTING OR MEASURING ANALYTES
#154TEST KIT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE POSITIVES
#155Spatially Encoded Biological Assays
#156HETEROGENEOUS SINGLE CELL PROFILING USING MOLECULAR BARCODING
#157COMPOSITIONS, DEVICES, AND METHODS OF IBS SENSITIVITY TESTING
#158Spatially Encoded Biological Assays
#159MULTI-CONFIGURABLE SENSING ARRAY AND METHODS OF USING SAME
#160Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease
#161ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES
#162FERRITIN MEASURING REAGENT
#163SURFACE-ENHANCED RAMAN SCATTERING SENSING PLATFORM AND DETECTION METHOD OF SUBSTANCE TO BE DETECTED USING THE SAME
#164Spatially Encoded Biological Assays
#165HIGH SENSITIVITY IMMUNOASSAY
#166Spatially Encoded Biological Assays
#167ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF
#168Spatially encoded biological assays
#169METHOD FOR DETECTING A ß-SHEET AGGREGATE FORM OF A PROTEIN FORMING ß-SHEET AGGREGATES
#170ASSAYS FOR FIXED DOSE COMBINATIONS
#171TARGET MEASUREMENT METHOD, TARGET MEASUREMENT DEVICE, TARGET MEASUREMENT APPARATUS, AND TARGET MEASUREMENT KIT
#172METHOD FOR MEASURING STEROL IN LIPOPROTEIN
#173METHOD FOR MEASURING FRAGMENTS CONTAINING HUMAN TYPE IV COLLAGEN 7S DOMAIN AND KIT FOR USE THEREIN
#174NOVEL CANCER BIOMARKER IN PANCREATIC CANCER OR MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM
#175METHODS AND DEVICES FOR DETECTION OF PERIPHERAL MEMBRANE PROTEIN INTERACTIONS USING NONLINEAR OPTICAL TECHNIQUES
#176CENTRIFUGAL REACTION DEVICE AND CENTRIFUGAL REACTION METHOD
#177CONCENTRATION DEVICE, SAMPLE SOLUTION CONCENTRATION METHOD, SAMPLE SOLUTION EXAMINATION METHOD, AND EXAMINATION KIT
#178EVALUATION METHOD FOR PROTEIN-CONTAINING SOLUTION
#179NEW METHOD AND KIT
#180LIPID NANOPILLAR ARRAY-BASED IMMUNOASSAY
#181BIOCHIP, METHOD FOR PRODUCING SAME, AND USE OF SAME
#182DETERMINATION OF DISEASE-SPECIFIC PROTEIN AGGREGATES IN STOOL SAMPLES
#183Method And System For Determining Intracellular Mediators' Activity
#184DEVICES FOR BIOLOGICAL SAMPLE COLLECTION AND ANALYSIS AND METHODS OF USE THEREOF
#185Compound Fixing Method, Detection Method, Screening Method, Substrate Used in Same, Compound Fixing Agent, and Fixing Kit
#186BIOLOGICAL VESICLE SURFACE BIOMARKER DETECTION DEVICE
#187METHODS AND COMPOSITIONS FOR MAKING AND USING PEPTIDE ARRAYS
#188Indicator-based analysis of a sample
#189ANALYTE DETECTION USING ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY-BASED IMAGINARY IMPEDANCE MEASUREMENT
#190PLASMON-ENHANCED FLUORO-DOT ASSAYS
#191MULTI-CHAMBERED ASSAY DEVICES AND ASSOCIATED METHODS, SYSTEMS AND APPARATUSES THEREOF FOR DETECTION OF ANALYTES
#192DECTECTION OF EXOSOMES AND EXOSOMAL BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS
#193SYSTEMS AND METHODS FOR LABEL-FREE DETECTION OF ANALYTES
#194Spatially encoded biological assays
#195ANALYSIS DEVICE AND ANALYSIS METHOD
#196SPATIALLY ENCODED BIOLOGICAL ASSAYS
#197Analysis and screening of cell secretion profiles
#198Spatially encoded biological assays
#199METHOD FOR DETERMINING ANTIBODY DISSOCIATION RATE
#200SYSTEMS AND METHODS USING MAGNETICALLY-RESPONSIVE SENSORS FOR DETERMINING A GENETIC CHARACTERISTIC
#201TRANSPOSITION-BASED DIAGNOSTICS METHODS AND DEVICES
#202Flow Cell and Automatic Analysis Device
#203SYSTEMS, DEVICES AND METHODS FOR CELL CAPTURE AND METHODS OF MANUFACTURE THEREOF
#204AUTOANTIBODIES AS BIOMARKERS FOR AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 1
#205METHOD FOR DETERMINING 5-METHYLCYTOSINE CONFIGURATIONS IN DNA
#206IMMUNOCHROMATOGRAPHIC STRIP, IMMUNOCHROMATOGRAPHIC DEVICE, IMMUNOCHROMATOGRAPHIC KIT, AND METHOD FOR DETECTING TEST SUBSTANCE
#207Spatially encoded biological assays
#208Spatially encoded biological assays correlating target nucleic acid to tissue section location
#209Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#210System and method for isolating and analyzing cells
#211MEASUREMENT METHOD AND MEASUREMENT REAGENT FOR ANALYTE USING IMMUNOREACTION
#212METHODS FOR DEVELOPING VIRUS PROTEIN-SPECIFIC CAPTURE AGENTS, CAPTURE AGENTS, AND METHODS OF USING THE CAPTURE AGENTS
#213METHODS AND KITS FOR DETECTING AUTOIMMUNE DISEASES
#214STANDARD SUBSTANCE FOR PSA QUANTIFICATION, PREPARATION METHOD THEREFOR, STANDARD SOLUTION FOR PSA QUANTIFICATION, AND PSA QUANTIFICATION METHOD
#215IMMUNOCHROMATOGRAPHIC KIT AND IMMUNOCHROMATOGRAPHIC METHOD
#216IMMUNOASSAY METHOD AND IMMUNOASSAY APPARATUS
#217ANTI-RS VIRUS-RECOGNIZING ANTIBODY, AND IMMUNOASSAY METHOD AND IMMUNOASSAY APPARATUS USING THE ANTIBODY
#218Modified TNF as a capture ligand
#219NOVEL ANTIBODIES FOR DETECTING GASTRIC CANCER
#220Drum Stencil
#221Spatially encoded biological assays
#222METHODS AND REAGENTS OF IMMUNOLOGICALLY DETECTING SARS-CoV-2
#223REAGENT KIT CONTAINING POLYPEPTIDE FOR USE IN DETECTION OF INTERMOLECULAR INTERACTIONS
#224METHOD OF PRODUCING BIOCHIPS
#225Large scale immunomagnetic separation device
#226A METHOD FOR DETECTING AN ANALYTE
#227METHOD AND KIT FOR DETECTING HUMAN a-DEFENSIN HD5, AND ANTIBODIES USED IN SAID METHOD AND KIT
#228MEASUREMENT METHOD USING ANTI-IMMUNOCOMPLEX ANTIBODY
#229XBP1 ISOFORM MULTIPLEX ASSAY
#230PROTEINS TARGETING ORTHOLOGS
#231Spatially encoded biological assays
#232Method for assigning antibody standard and determining minimum detection limit of antibody detection reagent
#233METHOD OF ASSISTING DIAGNOSIS OF METASTATIC CASTRATION RESISTANT PROSTATE CANCER
#234NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF
#235IMMUNOCHROMATOGRAPHY
#236Spatially encoded biological assays
#237IMMUNE MICROBUBBLE COMPLEX, AND USE THEREOF
#238MULTIPLE BIOMARKER SIMULTANEOUS ANALYSIS APPARATUS AND METHOD
#239METHOD AND SYSTEM FOR MEASURING ANALYTE CONCENTRATION IN A SAMPLE
#240Assay for the detection of alpha-synuclein seeding activity associated with synucleinopathies
#241ANALYSIS METHOD AND ANALYSIS DEVICE
#242Rapid bio/chemical assay
#243Spatially encoded biological assays
#244COATINGS WITH TUNABLE AMINE DENSITY
#245Multi-chambered assay devices and associated methods, systems and apparatuses thereof for detection of analytes
#246COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS
#247Compositions and methods for the detection of host cell proteins
#248MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS
#249SALIVA TESTING
#250DETECTABLE ARRAYS, SYSTEMS FOR DIAGNOSIS, AND METHODS OF MAKING AND USING THE SAME
#251METHODS FOR ANALYTE DETECTION AND ANALYSIS
#252DETECTION OF DESMOGLEIN-2 IN CANCERS OF EPITHELIAL ORIGIN
#253COMBINATION OF REVERSIBLE AND IRREVERSIBLE CELL LABELING FOR ANALIZING RECEPTOR-LIGAND KOFF RATE
#254Spatially resolved ligand-receptor binding assays
#255Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission
#256TEMPERATURE-RESPONSIVE FLUORESCENT PARTICLES FOR DETECTION OF BIOMOLECULES
#257ASSAY SYSTEM CALIBRATION SYSTEMS AND METHODS
#258METHOD AND APPARATUS FOR SUBSTRATE HANDLING AND PRINTING
#259System for analyzing targets of a tissue section
#260IMMUNOLOGICAL TEST METHOD AND CONCENTRATION JIG
#261Methods of classifying response to immunotherapy for cancer
#262SYSTEMS AND METHODS FOR MEASURING A CONCENTRATION OF AN ANALYTE
#263Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease
#264Analysis and screening of cell secretion profiles
#265Fluidic device for the detection, capture, or removal of a disease material
#266PROGRAMMABLE ARRAYS
#267DEVICE FOR DETECTION OF VITAMIN D METABOLITES
#268Detection method and system for detecting biological samples
#269CHIPS, DETECTORS, AND METHODS OF MAKING AND USING THE SAME
#270Monoclonal antibodies specific for the PB2 antigen of the human influenza A virus (flu), nucleotide sequences, method and diagnostic kit for flu infection
#271Spatially encoded biological assays
#272POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP
#273Inter-alpha inhibitor proteins
#274Methods and arrays for target analyte detection and determination of target analyte concentration in solution
#275SENSOR FOR SINGLE PARTICLE DETECTION
#276Bead-based analysis of a sample
#277NANOHOLE ARRAY BASED SENSORS WITH VARIOUS COATINGS AND TEMPERATURE CONTROL FOR COVID-19
#278Kits and methods to distinguish false labor and true labor
#279MICROTUBE
#280ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR
#281MONOCLONAL ANTIBODIES AGAINST SARS-CoV-2 NUCLEOCAPSID PROTEIN AND USES THEREOF
#282MONOCLONAL ANTIBODY AGAINST SPIKE S1 PROTEIN OF SARS-CoV-2 AND USE THEREOFOF
#283METHOD FOR DIAGNOSING A LIVER DISEASE
#284METHOD AND KIT FOR DETECTING T-CELLS
#285Physical and chemical characterization of aerosols with photonic waveguides
#286MEANS AND METHOD FOR POINT-OF-CARE ANALYSIS OF LIQUID SAMPLES
#287EXTENDED RANGE IMMUNOASSAY DEVICES WITH IMMUNOSENSOR AND MAGNETIC IMMUNOSENSOR
#288Multi-stage, multiplexed target isolation and processing from heterogeneous populations
#289SCREENING ASSAYS AND METHODS
#290ANALYTICAL METHODS AND ARRAYS FOR USE IN THE SAME
#291Articles and methods directed to personalized therapy of cancer
#292Method for treating a cancer based on inflammatory subtype thereof
#293Spatially encoded biological assays
#294Factor XIII immunoassay
#295DETECTING ADAPTIVE IMMUNITY TO CORONAVIRUS
#296Lateral flow assay housing and method of correcting color, intensity, focus, and perspective of an image of the test results
#297Target substance polymer replica substrate, method for producing same, and method for producing substrate sensor
#298Saturation binding ratiometric assay
#299Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease
#300Autofocus sample imaging apparatus and method